Tariq I Mughal

6PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCardiology (incl. cardiovascular diseases)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 18, 2025
Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1-Positive and -Negative Myeloproliferative Neoplasms.

Tariq I Mughal, John Mascarenhas, Raajit K Rampal

|Jul 12, 2022
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm.

Naveen Pemmaraju, Kendra L Sweet, Anthony S Stein

|May 17, 2021
Targeting CD123 in hematologic malignancies: identifying suitable patients for targeted therapy.

Mrinal M Patnaik, Tariq I Mughal, Christopher Brooks

|Jun 28, 2020
Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies.

Tariq I Mughal, Naveen Pemmaraju, Bethan Psaila

|Apr 24, 2019
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.

Tariq I Mughal, Naveen Pemmaraju, Jerald P Radich

|Aug 04, 2018
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms.

Tariq I Mughal, Thomas Lion, Omar Abdel-Wahab

Pageof 1

Frequent Collaborators

2 joint publications

Naveen Pemmaraju

1 joint publications

Tania Jain

1 joint publications

Mrinal M Patnaik

1 joint publications

Christopher Brooks